tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

Health care · Lab Instruments · NYSE

WATWaters Corporation

Compare with peers → Embed
The 10-K against last year's

223 changes: 98 added, 16 removed, 102 reworded, 7 quiet changes

10-K Feb 23, 2026 vs Feb 25, 2025
Risk FactorsRedline ↓
42.3%
of the text changed · 14,674 words now
34.7%
of the text changed · 7,625 words now
Accounting PoliciesRedline ↓
21.3%
of the text changed · 7,121 words now

10-K 0001193125-26-062604 (2026-02-23) vs 10-K 0001193125-25-034579 (2025-02-25) Not compared: Legal Proceedings.

The redline

The paragraph that changed most in each section

Marked against last year's 10-K: cut words struck through, new words highlighted and underlined.

Risk Factors 224 words changed in this paragraph; it is 51% similar to last year's version.
In particular, China’s government continues to play a significant role in regulating industry development by imposing sector-specific policies, and it maintains control over China’s economic growth through setting monetary policy and determining treatment of particular industries or companies. The U.S. government has called for substantial changes to foreign trade policy with China and has recently raised, and has proposed to further raise in the future, tariffs on several Chinese goods. China has retaliated with increased tariffs on U.S. goods, which may increase has increased our cost of doing business in China. Any further changes in Additionally, the U.S. government announced new global trade policy could trigger retaliatory actions by affected countries, tariffs on imports to the U.S. during fiscal 2025, including China, resulting in trade wars and increased costs for goods imported into additional tariffs on various countries from which the Company directly or indirectly imports and/or exports products. In response, several countries have imposed or threatened reciprocal tariffs on imports from the U.S. and impacting our other measures. Various modifications to the U.S. tariffs have been announced, and further changes are expected to be made in the future, including in response to litigation. On February 20, 2026, the U.S. Supreme Court rendered a decision invalidating tariffs imposed under the International Emergency Economic Powers Act. This decision introduces uncertainty regarding potential refund processes and future trade policy actions and could affect the Company’s cost structure and supply chain planning. The ultimate impact of tariffs and other trade policies on the Company’s business will depend on several factors, including future measures implemented by the U.S. government and the governments of other countries, the overall magnitude and duration of these measures, and the Company’s ability to sell our products mitigate effects, which could include higher import costs and reduced sales in China and other affected countries. markets. Accordingly, our the Company’s financial position or results of operations can may be adversely influenced by political, economic, legal, compliance, social and business conditions in China generally. the U.S. and in other countries.

Source: Item 1A, 10-K 0001193125-26-062604 vs Item 1A, 10-K 0001193125-25-034579

Accounting Policies 184 words changed in this paragraph; it is 60% similar to last year's version.
between segment revenue less the segment expenses disclosed under the significant expense principle and each reported measure of segment profit or loss), (3) provide all annual disclosures about a reportable segment’s profit or loss and assets currently required by Topic 280 in interim periods, (4) clarify that if the CODM uses more than one measure of a segment’s profit or loss in assessing segment performance and deciding how to allocate resources, a public entity may report one or more of those additional measures of segment profit. However, at least one of the reported segment profit or loss measures (or the single reported measure, if only one is disclosed) should be the measure that is most consistent with the measurement principles used in measuring the corresponding amounts in the public entity’s consolidated financial statements, (5) the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources, and (6) if a public entity has a single reportable segment to provide all the disclosures required by the amendments in this update and all existing segment disclosures in Topic 280. The amendments in this update do not change how operating segments are identified or aggregated nor how the quantitative thresholds are applied to determine its reportable segments. The amendments in this update are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendments in this update should be applied retrospectively to all prior periods presented in the financial statements. Upon transition, the segment expense categories and amounts disclosed in the prior periods should be based on the significant segment expense categories identified and disclosed in the period of adoption. The Company has adopted this accounting standard update and included its significant expense categories in Note 17 “Business Segment Information”.

Source: Item 8, Note 2 – Basis of Presentation and Summary of Significant Accounting Policies, 10-K 0001193125-26-062604 vs Item 8, Note 2 – Basis of Presentation and Summary of Significant Accounting Policies, 10-K 0001193125-25-034579

MD&A 180 words changed in this paragraph; it is 34% similar to last year's version.
In 2024, 2025, sales growth increased by 7% as compared to 2024. Sales growth was flat in 2024 as compared to 2023 2023. Geographically, the 2025 sales increase was broad based across most major regions and led by the sales declined by 1% in 2023 as compared to 2022. During these periods, the Company’s sales in most geographies grew positively, except growth in China and Japan. The Europe which both grew 10%. In 2024, China sales decreased 10% and Europe’s sales increased 4%. Sales in the U.S. increased 3% in 2025 and 1% in 2024, while sales in Asia Other increased 5% and 1% in 2025 and 2024, respectively. Foreign currency translation had a minimal overall impact on 2025 sales growth outside of China as the 6% favorable currency impact on Europe sales was led offset by India where sales increased 15% and 2% in 2024 and 2023, respectively. China’s sales declined by 10% and 22% in 2024 and 2023, respectively, and were primarily driven by lower demand for our instrument systems and chemistry products resulting from increased government regulations and lower spending by our customers due to macroeconomic conditions. Excluding China, the Company’s sales increased 2% and a 5% in 2024 and 2023, respectively. unfavorable impact on Asia sales. Foreign currency translation decreased sales growth by 1% in both 2024 and 2023. Wyatt sales increased the Company’s sales growth by 1% and 3% in 2024 and 2023, respectively, and added 3% to the U.S. sales. 2024.

Source: Item 7, 10-K 0001193125-26-062604 vs Item 7, 10-K 0001193125-25-034579

Every change, by type

Sentences and paragraphs added, removed or reworded

Sentences and paragraphs of WAT's Risk Factors and MD&A, 10-K 2026-02-23 against 10-K 2025-02-25. Each links to the text at sec.gov.

RemovedRisk Factors
Public health crises, epidemics or pandemics have had, and could in the future have, a negative impact on the Company’s business and operations.

Read it in 10-K 2025-02-25 at sec.gov ↗

RemovedRisk Factors
Public health crises, epidemics or pandemics have had, and could in the future have, a negative impact on our business and operations, including Company sales and cash flow. Such public health crises, epidemics and pandemics have the potential to create significant volatility, uncertainty and worldwide economic disruption, resulting in an economic slowdown of potentially extended duration, as seen with the COVID-19 pandemic from 2020 to 2022. The Company’s global operations expose it to risks associated with such public health crises, epidemics and pandemics, which could have an adverse effect on its business, results of operations and financial condition. The degree to which such public health crisis, epidemics or pandemics ultimately affects the Company’s business, results of operations and financial condition is highly uncertain and cannot be predicted.

Read it in 10-K 2025-02-25 at sec.gov ↗

RemovedRisk Factors
The demand for the Company’s products is dependent upon the size of the markets for its LC, LC-MS, light scattering, thermal analysis, rheometry and calorimetry products; the timing and level of capital spending and expenditures of the Company’s customers; changes in governmental regulations, particularly those affecting drug, food and drinking water testing; funding available to academic, governmental and research institutions;

Read it in 10-K 2025-02-25 at sec.gov ↗

RemovedRisk Factors
The Company’s software or hardware may contain coding or manufacturing errors that could impact their function, performance and security, and result in other negative consequences.

Read it in 10-K 2025-02-25 at sec.gov ↗

RemovedRisk Factors
The loss of key members of management and the risks inherent in succession planning could adversely affect the Company’s results of operations or financial condition.

Read it in 10-K 2025-02-25 at sec.gov ↗

RemovedRisk Factors
The operation of the Company requires managerial and operational expertise. None of the Company’s key management employees, with the exception of the Chief Executive Officer and Chief Financial Officer, have an employment contract with the Company and there can be no assurance that such individuals will remain with the Company. If, for any reason, other key personnel do not continue to be active in management, the Company’s results of operations or financial condition could be adversely affected. The Company’s success also depends on its ability to execute leadership succession plans. The inability to successfully transition key management roles could have a material adverse effect on the Company’s operating results.

Read it in 10-K 2025-02-25 at sec.gov ↗

RemovedRisk Factors
The Company is subject to the rules of the SEC under the Dodd-Frank Wall Street Reform and Consumer Protection Act, which require disclosure as to whether certain materials (tantalum, tin, gold and tungsten), known as conflict minerals, which may be contained in the Company’s products, are mined from the Democratic Republic of the Congo and adjoining countries. In 2023, the Company was not able to determine with certainty the country of origin of some of the conflict minerals in its manufactured products. However, the Company does not have knowledge that any of its conflict minerals originated from the Democratic Republic of the Congo or adjoining countries. The Company is in the process of evaluating its 2024 supply chain, and the Company plans to file its 2024 Form SD with the SEC in May 2025. The results of this and future evaluations may impose additional costs and may introduce new risks related to the Company’s ability to verify the origin of any conflict minerals contained in its products.

Read it in 10-K 2025-02-25 at sec.gov ↗

RemovedRisk Factors
The Company had $1.6 billion in debt and $325 million in cash, cash equivalents and investments as of December 31, 2024. As of December 31, 2024, the Company also had the ability to borrow an additional $1.6 billion from its existing, committed credit facility. All but a small portion of the Company’s debt was in the U.S. There is a substantial cash requirement in the United States to fund operations and capital expenditures, service debt interest obligations, finance potential United States acquisitions and continue authorized stock repurchase programs. As such, the Company’s financial condition and results of operations could be adversely impacted if the Company is unable to generate and maintain a sufficient level of cash flow to address these requirements through (1) cash from operations, (2) the Company’s ability to access its existing cash and revolving credit facility, (3) the ability to expand the Company’s borrowing capacity and (4) other sources of capital obtained at an acceptable cost.

Read it in 10-K 2025-02-25 at sec.gov ↗

Show the other 8
RemovedMD&A
The increase in 2023 is primarily driven by severance-related costs in connection with a reduction in workforce, which increased expenses by 4%; the Wyatt acquisition due diligence and integration costs, which increased expenses by 2%; and the Wyatt acquisition-related retention expense, which increased expenses by 3%. These increases were partially offset by lower incentive compensation costs. The increase in selling and administrative expenses in 2023 as compared to 2022 can be attributed to higher salary merit and variable incentive compensation costs due to an increase in the number of employees. The effect of foreign currency translation had minimal impact on selling and administrative expenses in 2024 and 2023.

Read it in 10-K 2025-02-25 at sec.gov ↗

RemovedMD&A
In 2022, the Company completed an asset acquisition in which the CDMS technology assets of Megadalton were acquired for approximately $10 million in total purchase price, of which $5 million was paid at closing and the remaining $4 million will be paid in the future at various dates through 2029.

Read it in 10-K 2025-02-25 at sec.gov ↗

RemovedMD&A
In 2022, the Company sold an equity investment for $10 million in cash and recorded a gain on the sale of approximately $7 million in other income, net on the statement of operations. The Company also incurred $6 million in losses on an equity investment in 2022 within other income, net on the statement of operations.

Read it in 10-K 2025-02-25 at sec.gov ↗

RemovedMD&A
Year Ended December 31, 2024 2023 2022 Net income $ 637,834 $ 642,234 $ 707,755 Depreciation and amortization 191,825 165,905 130,423 Stock-based compensation 44,709 36,868 42,564 Deferred income taxes (877) (1,197) (31,988) Acquired in-process research and development and other non-cash items — — 10,003 Change in accounts receivable (66,240) 49,179 (137,874) Change in inventories 20,943 (45,443) (101,902) Change in accounts payable and other current liabilities 61,585 (79,524) 60,984 Change in deferred revenue and customer advances 6,165 10,433 12,862 Other changes (133,821) (175,646) (81,166) Net cash provided by operating activities 762,123 602,809 611,661 Net cash used in investing activities (144,023) (1,442,265) (107,967) Net cash (used in) provided by financing activities (696,675) 754,951 (509,633) Effect of exchange rate changes on cash and cash equivalents 7,920 (948) (14,766) Decrease in cash and cash equivalents $ (70,655) $ (85,453) $ (20,705)

Read it in 10-K 2025-02-25 at sec.gov ↗

RemovedMD&A
During 2024, 2023 and 2022, the Company purchased $4 million, $2 million and $11 million of investments, respectively, while $4 million, $2 million and $78 million of investments matured, respectively, and were used for financing activities described below.

Read it in 10-K 2025-02-25 at sec.gov ↗

RemovedMD&A
In 2022, the Company paid $5 million for the CDMS technology and intellectual property right asset from Megadalton, and the Company is required to make an additional $4 million of guaranteed payments at various dates in the future through 2029. The total purchase price of approximately $10 million was accounted for as Acquired In-Process Research and Development and expensed as part of costs and operating expenses in the statement of operations in 2024.

Read it in 10-K 2025-02-25 at sec.gov ↗

RemovedMD&A
In our prior year acquisition of Wyatt in fiscal 2023, customer relationship intangible assets have been the most significant identifiable assets acquired. The customer relationships were valued using the multi-period excess earnings method under the income approach. Our cash flow projections for the customer relationships acquired included significant judgments and assumptions related to customer attrition rate, discount rate, and forecasted revenues. The value of the client relationships acquired was $331 million in fiscal year 2023, the majority of which relates to U.S. customer relationships.

Read it in 10-K 2025-02-25 at sec.gov ↗

Next Related parties →